In silico identification of approved drugs for potential prophylactic uses against SARS-CoV-2 infection
Crossref DOI link: https://doi.org/10.30574/msabp.2024.11.2.0023
Published Online: 2024-04-30
Update policy: https://doi.org/10.30574/msabp.ourcrossmarkpolicy
Roselyn N. Egbuna,
InnocentMary I. Ejiofor,
Emmanuel C. Oranu,
Ifeanyichukwu R. Iroha,
Ikemefuna C. Uzochukwu,
